Koninklijke DSM NV Top Insiders
Koninklijke DSM employs about 21.8 K people. The company is managed by 10 executives with a total tenure of roughly 36 years, averaging almost 3.0 years of service per executive, having 2176.0 employees per reported executive. Examination of Koninklijke DSM's management performance can provide insight into the company performance.
| Dave Huizing President Vice President Investor Relations |
Koninklijke |
Koninklijke DSM Management Team Effectiveness
The company has return on total asset (ROA) of 0.0402 % which means that it generated a profit of $0.0402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1189 %, meaning that it generated $0.1189 on every $100 dollars invested by stockholders. Koninklijke DSM's management efficiency ratios could be used to measure how well Koninklijke DSM manages its routine affairs as well as how well it operates its assets and liabilities.Koninklijke DSM Workforce Comparison
Koninklijke DSM NV is rated fourth overall in number of employees category among its peers. The total workforce of Specialty Chemicals industry is now estimated at about 169,088. Koninklijke DSM retains roughly 21,760 in number of employees claiming about 13% of equities listed under Specialty Chemicals industry.
The company has Profit Margin (PM) of 0.11 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.1 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.1. Koninklijke DSM Notable Stakeholders
A Koninklijke DSM stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Koninklijke DSM often face trade-offs trying to please all of them. Koninklijke DSM's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Koninklijke DSM's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Dave Huizing | Vice President Investor Relations | Profile | |
| Geraldine Matchett | CFO and Member of the Managing Board | Profile | |
| Jan Wolters | Head Chemicals | Profile | |
| Bruno Mller | Head Products | Profile | |
| Paul Gilgen | Head Products | Profile | |
| Manfred Eggersdorfer | VP Advocacy | Profile | |
| Lieke JongTops | Communications Mang | Profile | |
| Luca Rosetto | VP Products | Profile | |
| Dimitri Vreeze | Member of the Managing Board | Profile | |
| Rob Atsma | Head Nederland | Profile |
Koninklijke DSM Workforce Analysis
Traditionally, organizations such as Koninklijke DSM use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Koninklijke DSM within its industry.Koninklijke DSM Manpower Efficiency
Return on Koninklijke DSM Manpower
| Revenue Per Employee | 423K | |
| Revenue Per Executive | 920.4M | |
| Net Income Per Employee | 77K | |
| Net Income Per Executive | 167.6M | |
| Working Capital Per Employee | 124K | |
| Working Capital Per Executive | 269.8M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Koninklijke Pink Sheet
If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |